A Phase 1a/B Study Of The Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors

This study is for the treatment of advanced solid tumors.

Study phase: I

Primary disease category: Cancer

Secondary disease categories: Cancer, Lung Cancer

Sponsor: Endocyte

Protocol number: EC1456

Projected enrollment dates: April 2016 to July 2017

Official study title: A PHASE 1A/B STUDY OF THE FOLIC ACID-TUBULYSIN CONJUGATE EC1456 IN PATIENTS WITH ADVANCED SOLID TUMORS

ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT01999738